Cumberland Pharmaceuticals Inc
CPIX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001087294
No open-market purchases or sales by Cumberland Pharmaceuticals Inc insiders were filed in the last 90 days; 32 institutions reported holding it in 13F filings for Q2 2026, worth $16.0M in total; no superinvestor holds it.
Q1 2023 vs. Q4 2022
How the institutions holding Cumberland Pharmaceuticals Inc changed between Q4 2022 and Q1 2023.
All holders in Q1 2023All holders in Q4 2022
| Measure | Q4 2022 | Q1 2023 | Change |
|---|---|---|---|
| Holders | 23 | 21 | −2 |
| Shares | 2.49M | 2.45M | −45.8K (−1.8%) |
| Value | $5.61M | $4.77M | −$836.1K (−14.9%) |
New holders (1)
Institutions that held Cumberland Pharmaceuticals Inc at the end of Q1 2023 but not at the end of Q4 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Susquehanna International Group, LLP | 10,633 | $20.7K | 0.00% |
Sold out (3)
Institutions that held Cumberland Pharmaceuticals Inc at the end of Q4 2022 and filed for Q1 2023 without it.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| True Capital Management | 12,025 | $27.1K |
| Bank of America Corp | 9 | $20 |
| Simplex Trading, LLC | 97 | $0 |